Skip to content

Effect of Dexamethasone and Epinephrine on the Duration of Sciatic Nerve Blocks With Ropivacaine

Effect of Dexamethasone and Epinephrine on the Duration of Sciatic Nerve Blocks With Ropivacaine in Ankle and Foot Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02104778
Enrollment
90
Registered
2014-04-04
Start date
2014-04-30
Completion date
2016-07-31
Last updated
2015-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

The aim of the present study is to test that adding dexamethasone or epinephrine significantly prolongs the duration of sciatic nerve blocks with ropivacaine and that the magnitude of the effect differs among dexamethasone and epinehrine.

Detailed description

In a double-blinded trial utilizing single-injection sciatic nerve block, patients are randomly assigned to one of three groups: control: 0.5% ropivacaine adding normal saline; epinephrine: 0.5% ropivacaine adding epinephrine; dexamethasone: 0.5% ropivacaine adding dexamethasone. We assess time to first analgesic request after post-anaesthesia care unit discharge.

Interventions

DRUGDexamethasone

In dexamethasone group, dexamethasone 8 mg is added to 0.5% ropivacaine 20 ml for sciatic nerve block.

DRUGEpinephrine

Epinephrine 1:200,000 is added to 0.5% ropivacaine 20 ml for sciatic nerve block

Sponsors

Yeungnam University College of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists physical status I and II * patients undergoing elective hallux valgus repair

Exclusion criteria

* patients receiving chronic analgesic therapy * diabetes * peripheral neuropathies * psychiatric disorders * hypersensitivity to amide local anesthetics * renal disorders

Design outcomes

Primary

MeasureTime frameDescription
time to first analgesic request after postanesthetic care unit dischargefrom arrival in postanesthetic care unit to 72 hours after operationA blinded observer interview patients at arrival in postanesthetic care unit, 6 hour, 24 hour, 48 hour, 72 hour after operation.

Secondary

MeasureTime frameDescription
time of recovery of motor and sensory functions on the operated footfrom arrival in postanesthetic care unit to 72 hours after operationThe time of recovery of motor (ability to move the ankle) and sensory (recovery of normal pinprick sensation) functions on the operated foot is recorded by the blinded observer at arrival in postanesthetic care unit, 6 hour, 24 hour, 48 hour, 72 hour after operation.

Countries

South Korea

Contacts

Primary ContactSangjin Park, M.D.
apsj0718@naver.com82-53-620-3366

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026